Status:
COMPLETED
Diastolic Hyperemia-Free Ratio in Patients With CAD
Lead Sponsor:
Yonsei University
Collaborating Sponsors:
Severance Hospital
Boston Scientific Corporation
Conditions:
Coronary Stenosis
Coronary Artery Disease
Eligibility:
All Genders
19+ years
Brief Summary
The investigators aimed to identify the value of concordance between the diastolic hyperemia-free ratio (DFR) and fractional flow reserve (FFR) during pre-interventional and post-interventional period...
Detailed Description
The physiologic assessment of coronary artery disease and ischemia-guided percutaneous coronary intervention (PCI) has become a standard practice for patients with coronary artery disease. Fractional ...
Eligibility Criteria
Inclusion
- Patients, ≥ 19 years of age, who are diagnosed with stable angina pectoris including silent ischemic heart disease and 50\~90% stenosis of the coronary artery.
- Acute coronary syndrome patients with multivessel disease who have 50\~90% stenosis of a non-culprit vessel on coronary angiography.
Exclusion
- Patients with acute coronary syndrome and single vessel disease.
- Patients with hypersensitivity or contraindication to antiplatelet treatment.
- Female of childbearing potential, who possibly plan to become pregnant any time after enrollment into this study.
- Patients with a life expectancy shorter than 1 year.
Key Trial Info
Start Date :
August 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 7 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05421169
Start Date
August 23 2022
End Date
March 7 2024
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yongin Severance Hospital
Yongin, Gyeonggi-do, South Korea, 16995